Historical shareholding details of UBS Asset Mgmt Americas Inc holdings in Celldex Therapeutics Inc. (CLDX)

Monthly changes of UBS Asset Mgmt Americas Inc shareholding in Celldex Therapeutics Inc. over the previous months

Month Name Total no. shares held Percent Holding
Dec 31, 2024 Ubs Asset Mgmt Americas Inc 116,317 0.18%
Sep 30, 2024 Ubs Asset Mgmt Americas Inc 102,595 0.15%
Jun 30, 2024 Ubs Asset Mgmt Americas Inc 96,326 0.15%
Mar 31, 2024 Ubs Asset Mgmt Americas Inc 38,709 0.06%
Dec 31, 2023 Ubs Asset Mgmt Americas Inc 34,868 0.05%
Sep 30, 2023 Ubs Asset Mgmt Americas Inc 34,868 0.06%
Jun 30, 2023 Ubs Asset Mgmt Americas Inc 31,748 0.07%
Mar 31, 2023 Ubs Asset Mgmt Americas Inc 31,748 0.07%
Dec 31, 2022 Ubs Asset Mgmt Americas Inc 30,242 0.06%

View all ownership details of Celldex Therapeutics Inc.